CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs. Ticagrelor in Stabilized Patients with Acute Myocardial Infarction after Percutan eous Coronary Intervention: rationale and design of the TALOS-AMI trial Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial 1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement

Clinical Trial2013 Apr 16;61(15):1596-600.

JOURNAL:J Am Coll Cardiol. Article Link

Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study

Weisz G, Metzger DC, Caputo RP et al. Keywords: angioplasty; robotic-enhanced PCI; stent

Full Text PDF